7D2A.F SEDANA MEDICAL AB
- Market cap
- EUR 77.5M
- P/E
- -
- P/B
- 1.03x
- ROE
- -3.7%
- Dividend yield
- -
- Fundamental score
- -
Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Sep 2026.
Is 7D2A.F undervalued?
Graham numberThe Graham number of SEDANA MEDICAL AB cannot be estimated reliably (it needs positive earnings and book value).
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
SEDANA MEDICAL AB fundamental analysis
No fundamental analysis for SEDANA MEDICAL AB yet.
SEDANA MEDICAL AB stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About SEDANA MEDICAL AB
Sedana Medical AB (publ), a medtech and pharmaceutical company, develops, manufactures, and sells medical devices and pharmaceutical products in Sweden, Spain, Germany, and internationally. The company offers Sedaconda ACD-L and Sedaconda ACD-S, which are disposable medical devices that enable the administration of volatile anaesthetics; Sedaconda Syringe, a syringe with a connection to fit the connector on the agent line of the Sedaconda ACD and Sedana Medical filling adapt…
Full company profileSEDANA MEDICAL AB financial statements
2026 annualized: Fiscal year 2026 is not finished. Income statement and cash flow are annualized from 3 quarters up to Sep 30, 2026, the balance sheet is the latest quarter. Figures change when the annual report is published.
SEDANA MEDICAL AB annual financial statements (SEK; K = thousand, M = million, B = billion, T = trillion)
| Item | 2022 | 2023 | 2024 | 2025 | 2026 Anlz |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | 123M | 154M | 179M | 200M | 196M |
| Gross Profit | 86.1M | 109M | 126M | 143M | 139M |
| Operating Income | -104M | -66.6M | -50.8M | -32.6M | -39.4M |
| EBITDA | -48.8M | -33.9M | 13.4M | -33.8M | -9.44M |
| Net Income | -73.5M | -59.6M | -10.7M | -59.2M | -32.6M |
| EPS | -0.74 | -0.60 | -0.11 | -0.60 | -0.33 |
| Balance Sheet | |||||
| Total Assets | 1.08B | 1.01B | 1.02B | 954M | 930M |
| Total Liabilities | 52.4M | 44.1M | 61.2M | 53.7M | 52.3M |
| Shareholders' Equity | 1.03B | 970M | 958M | 901M | 877M |
| Cash & Short-term Investments | 608M | 231M | 194M | 91.0M | 39.7M |
| Cash Flow | |||||
| Operating Cash Flow | -115M | -38.1M | -11.8M | -12.8M | -10.6M |
| Capital Expenditure | 138M | 169M | 175M | 62.4M | 58.5M |
| Free Cash Flow | -253M | -207M | -187M | -75.2M | -69.1M |
| Ratios | |||||
| ROE | -7.1% | -6.1% | -1.1% | -6.6% | -3.7% |
| ROA | -6.8% | -5.9% | -1.0% | -6.2% | -3.5% |
| Net Profit Margin | -59.8% | -38.7% | -6.0% | -29.6% | -16.7% |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
SEDANA MEDICAL AB dividends
SEDANA MEDICAL AB has not paid dividends in the last 4 fiscal years.
Last stock split: 4:1 on May 26, 2021.
Who owns SEDANA MEDICAL AB
- Insiders 18.64%
- Institutions 46.56%
- Public & others 34.80%
- Shares outstanding 99.3M
- Free float 61.9M
SEDANA MEDICAL AB company profile
- Company name
- SEDANA MEDICAL AB
- Ticker
- 7D2A.F
- ISIN
- SE0015988373
- Exchange
- Frankfurt Exchange
- Sector
- Healthcare
- Industry
- Health Care Equipment & Supplies
- Employees
- 116
- Fiscal year end
- December
- Address
- Svärdvägen 3A, Danderyd, Sweden, 182 33
- Phone
- 46 8 12 40 52 00
- Website
- sedanamedical.com
About SEDANA MEDICAL AB
Sedana Medical AB (publ), a medtech and pharmaceutical company, develops, manufactures, and sells medical devices and pharmaceutical products in Sweden, Spain, Germany, and internationally. The company offers Sedaconda ACD-L and Sedaconda ACD-S, which are disposable medical devices that enable the administration of volatile anaesthetics; Sedaconda Syringe, a syringe with a connection to fit the connector on the agent line of the Sedaconda ACD and Sedana Medical filling adapters; Sedaconda ACD starter kit; Sedaconda (Isoflurane) for maintenance of sedation in intubated or tracheostomised mechanically ventilated adult and paediatric patients from 3 years of age; Sedaconda Filling Adapter, a single-use medical device; FlurAbsorb Pro-L and Pro-S; FlurAbsorb and Mounts; Scavenging Tube, a one piece pre-connected tube, that is designed to channel anaesthetic waste gas from the ventilator exhaust port and the gas monitor exhaust port to the FlurAbsorb filter; and Mindray exhaust connector enables to connect the exhaust of the ventilator to an active or passive scavenging system. The company was founded in 1999 and is headquartered in Danderyd, Sweden.
SEDANA MEDICAL AB management
10- Mr. Johannes DollGroup CEO & President · born 1981
- Mr. Mikael HaagChief Financial Officer · born 1975
- Mr. David BergstromVice President of Operations, Supply and R&D · born 1969
- Ms. Karolina Vilval L.L.M.General Counsel · born 1979
- Ms. Sinead Renouf-WoodVice President of Marketing · born 1986
- Ms. Karolin SjostenVice President of Human Resources · born 1979
- Mr. Peter Sackey M.D., Ph.D.Chief Medical Officer · born 1971
- Mr. Stefan KrischSupply Chain & Manufacturing Director · born 1974
- Mr. Jessica WestfalVP of Regulatory Affairs and QA · born 1974
- Mr. Uwe VeismannGeneral Manager of Germany, Nordics & Benelux · born 1981